Neuroprotective aminothiazoles
US11220498B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Inventor
Key dates
| Filing date | Dec 1, 2019 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Dec 1, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and compositions comprising compounds capable of activating and increasing protein SUMOylation. Disclosed herein are methods and compositions comprising compounds capable of showing neuroprotective and cytoprotective effects when administered to injured cells. Also disclosed are methods comprising these compounds for treating neuronal or neurological disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, fronto-temporal dementia, chronic traumatic encepholopathy, traumatic brain injury, or stroke.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.